This analyze proposes that K2's superior adverse impact event is due, no less than partly, to unique JWH-018 metabolite exercise on the cannabinoid 1 receptor (CB1R), and indicates that metabolites of most medicine, although not the carboxy metabolite, keep in vitro and in vivo activity at CB1Rs. Table 1 Affinities https://eam-220197530.theisblog.com/31321267/what-does-am-2201-mean